• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏重症监护病房中心源性休克的管理

Management of Cardiogenic Shock in a Cardiac Intensive Care Unit.

作者信息

Kim Ju H, Sunkara Anusha, Varnado Sara

机构信息

HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.

HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.

出版信息

Methodist Debakey Cardiovasc J. 2020 Jan-Mar;16(1):36-42. doi: 10.14797/mdcj-16-1-36.

DOI:10.14797/mdcj-16-1-36
PMID:32280416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7137626/
Abstract

Cardiogenic shock (CS) is a complex condition characterized by end-organ hypoperfusion and requiring pharmacologic and/or mechanical circulatory support. It is caused by a decline in cardiac output due to a primary cardiac disorder. CS is frequently complicated by multiorgan system dysfunction that requires a multidisciplinary approach in a critical care setting. Appropriate use of diagnostic data using tools available in a modern cardiac intensive care unit should guide optimal management incorporating both pharmacologic and nonpharmacologic therapies to minimize morbidity and mortality.

摘要

心源性休克(CS)是一种复杂的病症,其特征为终末器官灌注不足,需要药物和/或机械循环支持。它由原发性心脏疾病导致的心输出量下降引起。CS常并发多器官系统功能障碍,在重症监护环境中需要多学科方法来处理。利用现代心脏重症监护病房中可用的工具合理使用诊断数据,应指导采用药物和非药物疗法的最佳管理,以尽量降低发病率和死亡率。

相似文献

1
Management of Cardiogenic Shock in a Cardiac Intensive Care Unit.心脏重症监护病房中心源性休克的管理
Methodist Debakey Cardiovasc J. 2020 Jan-Mar;16(1):36-42. doi: 10.14797/mdcj-16-1-36.
2
Mechanical circulatory support in patients with cardiogenic shock in intensive care units: A position paper of the "Unité de Soins Intensifs de Cardiologie" group of the French Society of Cardiology, endorsed by the "Groupe Athérome et Cardiologie Interventionnelle" of the French Society of Cardiology.重症监护病房心源休克患者的机械循环支持:法国心脏病学会“心血管重症监护”工作组的立场文件,得到法国心脏病学会“动脉粥样硬化与心血管介入”工作组的认可。
Arch Cardiovasc Dis. 2018 Oct;111(10):601-612. doi: 10.1016/j.acvd.2018.03.008. Epub 2018 Jun 11.
3
A team-based approach to patients in cardiogenic shock.一种针对心源性休克患者的团队协作方法。
Catheter Cardiovasc Interv. 2016 Sep;88(3):424-33. doi: 10.1002/ccd.26297. Epub 2015 Nov 3.
4
Management of refractory cardiogenic shock.难治性心源性休克的治疗。
Nat Rev Cardiol. 2016 Aug;13(8):481-92. doi: 10.1038/nrcardio.2016.96. Epub 2016 Jun 30.
5
Acute myocardial infarction and cardiogenic shock: pharmacologic and mechanical hemodynamic support pathways.急性心肌梗死与心源性休克:药物及机械血流动力学支持途径
Coron Artery Dis. 2015 Sep;26(6):535-44. doi: 10.1097/MCA.0000000000000259.
6
Cardiogenic Shock in the Setting of Acute Myocardial Infarction.急性心肌梗死背景下的心源性休克
Methodist Debakey Cardiovasc J. 2020 Jan-Mar;16(1):16-21. doi: 10.14797/mdcj-16-1-16.
7
Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.经皮 Impella 辅助治疗伴心原性休克的急性心肌梗死。
Circulation. 2019 Mar 5;139(10):1249-1258. doi: 10.1161/CIRCULATIONAHA.118.036614.
8
Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.急性心肌梗死合并心源性休克早期机械循环支持的可行性:底特律心源性休克倡议
Catheter Cardiovasc Interv. 2018 Feb 15;91(3):454-461. doi: 10.1002/ccd.27427. Epub 2017 Dec 20.
9
The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.能够实现完全血运重建与因心肌梗死导致的心源性休克患者住院期间生存率的提高相关:马尼托巴省心源性休克注册研究人员。
Catheter Cardiovasc Interv. 2011 Oct 1;78(4):540-8. doi: 10.1002/ccd.23006. Epub 2011 May 5.
10
Systems of Care in Cardiogenic Shock.心源性休克的护理系统
Methodist Debakey Cardiovasc J. 2020 Jan-Mar;16(1):50-56. doi: 10.14797/mdcj-16-1-50.

引用本文的文献

1
Guideline-directed medical therapy implementation during hospitalization for cardiogenic shock.在心源性休克住院期间实施指南指导的药物治疗。
ESC Heart Fail. 2025 Feb;12(1):60-70. doi: 10.1002/ehf2.14863. Epub 2024 Sep 26.
2
Venous-arterial extracorporeal membrane oxygenation for psittacosis pneumonia complicated with cardiogenic shock: case report and literature review.静脉-动脉体外膜肺氧合治疗鹦鹉热肺炎合并心源性休克:病例报告及文献复习。
BMC Cardiovasc Disord. 2024 Jan 2;24(1):6. doi: 10.1186/s12872-023-03669-y.
3
National outcomes of urgent vs. non-urgent percutaneous edge-to-edge transcatheter mitral valve repair.紧急与非紧急经皮缘对缘经导管二尖瓣修复术的全国性结果
Int J Cardiol Heart Vasc. 2022 Jul 16;41:101087. doi: 10.1016/j.ijcha.2022.101087. eCollection 2022 Aug.
4
The CSP (Cardiogenic Shock Prognosis) Score: A Tool for Risk Stratification of Cardiogenic Shock.心源性休克预后(CSP)评分:一种用于心源性休克风险分层的工具。
Front Cardiovasc Med. 2022 Mar 7;9:842056. doi: 10.3389/fcvm.2022.842056. eCollection 2022.
5
Risk stratification in cardiogenic shock: a focus on the available evidence.心源性休克的风险分层:关注现有证据。
Heart Fail Rev. 2022 Jul;27(4):1105-1117. doi: 10.1007/s10741-021-10140-7. Epub 2021 Jul 14.

本文引用的文献

1
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness.心脏重症监护病房患者的人口统计学、护理模式和结局:重症心脏病学试验网络前瞻性北美多中心心脏危重症登记研究。
JAMA Cardiol. 2019 Sep 1;4(9):928-935. doi: 10.1001/jamacardio.2019.2467.
2
Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock.急性心肌梗死后合并心原性休克所致的非心脏器官功能衰竭。
J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791. doi: 10.1016/j.jacc.2019.01.053.
3
Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock.心力衰竭伴或不伴心源性休克患者肺动脉导管使用及结局的变化趋势。
J Card Fail. 2019 May;25(5):364-371. doi: 10.1016/j.cardfail.2019.03.004. Epub 2019 Mar 8.
4
Ultrafiltration in Acute Heart Failure.急性心力衰竭中的超滤
Card Fail Rev. 2019 Feb;5(1):9-18. doi: 10.15420/cfr.2018.29.2.
5
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.肾上腺素与去甲肾上腺素治疗急性心肌梗死后心源性休克。
J Am Coll Cardiol. 2018 Jul 10;72(2):173-182. doi: 10.1016/j.jacc.2018.04.051.
6
Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.心力衰竭患者住院后的指南导向性药物治疗与生存情况
Pharmacotherapy. 2018 Apr;38(4):406-416. doi: 10.1002/phar.2091. Epub 2018 Mar 22.
7
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.用于治疗心源性休克或低心输出量综合征的正性肌力药物和血管扩张剂策略。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD009669. doi: 10.1002/14651858.CD009669.pub3.
8
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.当代心源性休克管理:美国心脏协会的科学声明
Circulation. 2017 Oct 17;136(16):e232-e268. doi: 10.1161/CIR.0000000000000525. Epub 2017 Sep 18.
9
Acute Noncardiovascular Illness in the Cardiac Intensive Care Unit.心脏重症监护病房中的急性非心血管疾病。
J Am Coll Cardiol. 2017 Apr 25;69(16):1999-2007. doi: 10.1016/j.jacc.2017.02.033.
10
Nomenclature for renal replacement therapy in acute kidney injury: basic principles.急性肾损伤中肾脏替代治疗的命名:基本原则
Crit Care. 2016 Oct 10;20(1):318. doi: 10.1186/s13054-016-1489-9.